<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01717508</url>
  </required_header>
  <id_info>
    <org_study_id>2012P001844</org_study_id>
    <secondary_id>2011A053424</secondary_id>
    <secondary_id>2011A051965</secondary_id>
    <secondary_id>2010A054978</secondary_id>
    <secondary_id>K23MH097786</secondary_id>
    <nct_id>NCT01717508</nct_id>
  </id_info>
  <brief_title>Neural Components Underlying the Treatment of Adolescent Depression</brief_title>
  <official_title>Examination of the Neural Components Underlying the Treatment of Adolescent Major Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mclean Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Mclean Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of the study is to examine how cognitive behavioral therapy (CBT), a common&#xD;
      treatment for adolescent depression, affects brain functioning. Depressed adolescents will&#xD;
      complete an initial assessment consisting of an interview, questionnaires, computer tasks,&#xD;
      and an EEG recording. EEG (electroencephalography) measures brain activity by recording the&#xD;
      electrical activity along the scalp caused by the firing of neurons within the brain. They&#xD;
      will then complete 12 sessions of cognitive behavioral therapy, which will be 50 minutes long&#xD;
      and held once a week for 12 weeks. Before their third therapy session, participants will&#xD;
      complete a computer task while EEG data are recorded. After completing the treatment, the&#xD;
      participants will complete a final assessment, which will include questionnaires, computer&#xD;
      tasks, and an EEG recording. They will also complete follow-up assessments over the phone 1,&#xD;
      3, and 6 months after completing the treatment.&#xD;
&#xD;
      This study will also include healthy control participants. They will complete an initial&#xD;
      assessment consisting of an interview, questionnaires, computer tasks, and an EEG recording.&#xD;
      Three weeks later, they will return to complete a behavioral task while EEG data are&#xD;
      recorded. Twelve weeks after the initial assessment, they will complete a final assessment,&#xD;
      which will include questionnaires, computer tasks, and an EEG recording.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is to examine the impact of individual cognitive behavioral therapy&#xD;
      (CBT) for adolescent depression on neural functioning. Specifically, the study will utilize&#xD;
      Brent and Poling's (1997) cognitive behavioral therapy (CBT) manual (Cognitive Therapy&#xD;
      Treatment Manual for Depressed and Suicidal Youth), and investigators will examine pre- to&#xD;
      post- neural activity patterns for children and adolescents who receive individual CBT for&#xD;
      depression. Electroencephalography (EEG) techniques will be utilized to assess&#xD;
      treatment-related effects on brain activity (i.e., anterior cingulate cortex and dorsolateral&#xD;
      prefrontal cortex functioning). Neural activity patterns will also be compared to&#xD;
      non-depressed, healthy controls.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">June 30, 2019</completion_date>
  <primary_completion_date type="Actual">June 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>EEG Activity</measure>
    <time_frame>12 weeks</time_frame>
    <description>EEG and ERP measures collected during resting state and behavioral tasks</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">112</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>Cognitive Behavioral Therapy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>12 weekly sessions of cognitive behavioral therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy</intervention_name>
    <description>12 sessions of cognitive behavioral therapy</description>
    <arm_group_label>Cognitive Behavioral Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria, Major Depressive Disorder Participants:&#xD;
&#xD;
          -  Ages 13-18 years at time of initial assessment&#xD;
&#xD;
          -  Female&#xD;
&#xD;
          -  Current major depressive disorder (MDD) diagnosed according to the K-SADS Axis I&#xD;
             semi-structured interview&#xD;
&#xD;
          -  English as first language or English fluency&#xD;
&#xD;
        Exclusion Criteria, Major Depressive Disorder Participants:&#xD;
&#xD;
          -  Male&#xD;
&#xD;
          -  Mania/Hypomania&#xD;
&#xD;
          -  Current anxiety disorders [e.g., Panic Disorder (PD), Generalized Anxiety Disorder&#xD;
             (GAD), Obsessive Compulsive Disorder (OCD)]&#xD;
&#xD;
          -  Eating Disorders&#xD;
&#xD;
          -  Substance Abuse/Dependency&#xD;
&#xD;
          -  Conduct Disorder/Antisocial Disorder&#xD;
&#xD;
          -  ADHD&#xD;
&#xD;
          -  Psychosis&#xD;
&#xD;
          -  Mental Retardation&#xD;
&#xD;
          -  Organic Brain Syndrome&#xD;
&#xD;
          -  Current Psychotherapy Treatment&#xD;
&#xD;
          -  Medical &amp; neurological illness (head injury, loss of consciousness for more than 5&#xD;
             minutes, seizures)&#xD;
&#xD;
          -  Current use of psychotropic medication for treatment of MDD with the exception of&#xD;
             SSRIs (selective serotonin reuptake inhibitors)&#xD;
&#xD;
          -  Active suicidality&#xD;
&#xD;
        Inclusion Criteria, Healthy Control Participants:&#xD;
&#xD;
          -  Ages 13-18 years at time of initial assessment&#xD;
&#xD;
          -  Female&#xD;
&#xD;
          -  English as first language or English fluency&#xD;
&#xD;
        Exclusion Criteria, Healthy Control Participants (in addition to the exclusion criteria of&#xD;
        the MDD group):&#xD;
&#xD;
          -  Elevated depressive symptoms as assessed in phone screen&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Randy P Auerbach, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mclean Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>McLean Hospital</name>
      <address>
        <city>Belmont</city>
        <state>Massachusetts</state>
        <zip>02478</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>October 23, 2012</study_first_submitted>
  <study_first_submitted_qc>October 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 30, 2012</study_first_posted>
  <last_update_submitted>February 21, 2020</last_update_submitted>
  <last_update_submitted_qc>February 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mclean Hospital</investigator_affiliation>
    <investigator_full_name>Randy P. Auerbach</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>MDD</keyword>
  <keyword>depression</keyword>
  <keyword>major depressive disorder</keyword>
  <keyword>adolescent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

